Documents
Sources and prices of selected drugs and diagnostics for people living with HIV/AIDS
04 de julio de 2004
This report provides data on the different sources and price ranges of HIV/AIDS drugs. It documents marketing information to help procurement agencies make informed decisions on the source of drugs; manufacturers interested in supplying HIV-related drugs and diagnostics at reduced prices; and the availability and price range of antiretroviral drugs for combination therapy. The report also includes information on essential drugs used to treat a wide range of opportunistic infections, pain-relieving drugs for use in palliative care, and drugs for the treatment of HIV/AIDS-related cancer. For the first time, it provides information on the range of test kits available for the diagnosis of HIV.
Related
UNAIDS welcomes the decision by the US Secretary of State to continue life-saving HIV treatment and convenes partners to assess and mitigate impacts on HIV services

29 de enero de 2025
Indicators and questions for monitoring progress on the 2021 Political Declaration on HIV and AIDS — Global AIDS Monitoring 2025
17 de diciembre de 2024
Take the rights path to end AIDS — World AIDS Day report 2024
26 de noviembre de 2024
Peru approves groundbreaking law to extend health coverage for migrants with HIV and TB

21 de octubre de 2024
2024 global AIDS report — The Urgency of Now: AIDS at a Crossroads
22 de julio de 2024
Youth Next Level: guidance to strengthen sustainable youth-led HIV responses
19 de julio de 2024
Youth-led responses: a definition for stakeholders supporting youth leadership in the HIV response
19 de julio de 2024